Prostate cancer treatment unblinded.
Publication
, Other
Tsivian, M; Abern, MR; Polascik, TJ
Published in: Lancet Oncol
June 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
June 2012
Volume
13
Issue
6
Start / End Page
567 / 568
Location
England
Related Subject Headings
- Ultrasonic Surgical Procedures
- Quality of Life
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Male
- Humans
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Tsivian, M., Abern, M. R., & Polascik, T. J. (2012). Prostate cancer treatment unblinded. Lancet Oncol. England. https://doi.org/10.1016/S1470-2045(12)70136-5
Tsivian, Matvey, Michael R. Abern, and Thomas J. Polascik. “Prostate cancer treatment unblinded.” Lancet Oncol, June 2012. https://doi.org/10.1016/S1470-2045(12)70136-5.
Tsivian M, Abern MR, Polascik TJ. Prostate cancer treatment unblinded. Vol. 13, Lancet Oncol. 2012. p. 567–8.
Tsivian, Matvey, et al. “Prostate cancer treatment unblinded.” Lancet Oncol, vol. 13, no. 6, June 2012, pp. 567–68. Pubmed, doi:10.1016/S1470-2045(12)70136-5.
Tsivian M, Abern MR, Polascik TJ. Prostate cancer treatment unblinded. Lancet Oncol. 2012. p. 567–568.
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
June 2012
Volume
13
Issue
6
Start / End Page
567 / 568
Location
England
Related Subject Headings
- Ultrasonic Surgical Procedures
- Quality of Life
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Male
- Humans
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis